Gerald E. Connolly Esophageal Cancer Awareness Act of 2025
Latest Action
Became Public Law No: 119-96.
Official Summary
Esophageal Cancer Awareness Act This bill requires the Government Accountability Office to report to Congress on (1) the impact of esophageal cancer-related health care spending under the Federal Employees Health Benefits Program (FEHBP) for federal employees and retirees diagnosed with esophageal cancer, and (2) how often FEHBP participants with a high risk of esophageal cancer undergo screenings according to established guidelines.
GovScope Watchdog™
AI Government Intelligence™The Gerald E. Connolly Esophageal Cancer Awareness Act of 2025 mandates the Government Accountability Office (GAO) to produce a report for Congress. This report will focus on two main areas: the financial impact of esophageal cancer-related healthcare costs within the Federal Employees Health Benefits Program (FEHBP) for federal employees and retirees diagnosed with esophageal cancer, and the frequency with which FEHBP participants at high risk for esophageal cancer receive screenings in accordance with established medical guidelines.
This law directs the GAO to analyze esophageal cancer healthcare spending and screening rates among federal employees and retirees under FEHBP, providing Congress with data to inform future decisions.
- Requires GAO to report on esophageal cancer-related healthcare spending under FEHBP.
- Requires GAO to assess screening rates for high-risk FEHBP participants based on established guidelines.
- Focuses on federal employees and retirees covered by the Federal Employees Health Benefits Program.
['Federal employees and retirees covered by FEHBP', 'Congress, through enhanced oversight and data for policymaking', 'Government Accountability Office, by expanding its reporting responsibilities']
['The bill does not specify funding sources or budget allocations for the GAO report, which could affect implementation timelines.', 'The effectiveness of the report depends on the availability and quality of FEHBP data on esophageal cancer diagnoses and screenings.', 'The bill does not mandate subsequent actions based on the GAO report findings, potentially limiting policy impact.']
The bill was introduced and passed during the 119th Congress and became Public Law No: 119-96 on June 9, 2026. It falls under the policy area of Government Operations and Politics, reflecting congressional interest in healthcare oversight within federal employee benefit programs.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['The GAO report may prompt future legislative or administrative actions to improve esophageal cancer screening and treatment within FEHBP.', 'Increased awareness of esophageal cancer costs and screening rates could influence healthcare policy discussions related to federal employee benefits.', 'The report might encourage other federal health programs to evaluate their cancer-related healthcare spending and screening practices.']
This bill enhances congressional oversight by requiring a GAO report on a specific health issue within a federal benefits program. Transparency depends on GAO's access to detailed and accurate FEHBP data. The absence of specified funding for the report and lack of mandated follow-up actions are important considerations for monitoring implementation and impact.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.